Migrant Workers' Responses to the COVID-19 Pandemic

Coronavirus Clinical Trial

Official title:

Responses of International Migrant Workers to Large-Scale Dormitory Outbreaks of COVID-19: A Population Survey

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04718519
• Other study ID #: 510d2
• Status: Completed
• Start date: June 22, 2020
• Est. completion date: October 11, 2020

Study information

• Verified date: April 2021
• Source: Yale-NUS College
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Rumors circulate widely during public health crises and have deleterious consequences. In this study, we seek to document the base rates of migrant workers' rumor exposure and identify predictors of rumor hearing, sharing and belief.

Description:

Rumors circulate widely during public health crises and have deleterious consequences. Vulnerable populations such as migrant workers tend to lack access to accurate health information, which can put them at higher risk for receiving and spreading misinformation.

In this study, we seek to document (i) the base rates of migrant workers' rumor exposure and (ii) identify predictors of rumor hearing, sharing and belief. These predictors include trust in institutions, risk perceptions, online habits and socio-demographic variables.

Data was taken from the COVID-19 Migrant Health Study, a cross-sectional study of male migrants employed in manual labor jobs within Singapore.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1011
• Est. completion date: October 11, 2020
• Est. primary completion date: October 11, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 21 Years to 60 Years

Eligibility

Inclusion Criteria:

• At least 21 years old

• Holds a government work permit identifying their employment status

Exclusion Criteria:

• NIL

Related Conditions & MeSH terms

• Coronavirus
• Coronavirus Infections
• Misinformation
• Trust

Locations

Country	Name	City	State
Singapore	Yale NUS	Singapore

Sponsors (1)

Lead Sponsor	Collaborator
Yale-NUS College

Country where clinical trial is conducted

Singapore, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Confidence in government	Participants were asked how confident they were that the government could control the nationwide spread of COVID-19	baseline
Primary	Fear for health	Participants were asked how fearful they were about their health during the COVID-19 situation	baseline
Primary	Fear for job	Participants were asked how fearful they were about their job during the COVID-19 situation	baseline
Primary	Degree of exposure to rumours	We investigated participants' familiarity with five rumors that had been widely spread during the COVID-19 pandemic: (1) drinking water frequently will help prevent infection (COVID-19 prevention); (2) eating garlic can help prevent infection (COVID-19 prevention); (3) the outbreak arose from people eating bat soup (COVID-19 origins); (4) the virus was created in a US lab to affect China's economy (COVID-19 origins); and (5) the virus was created in a Chinese lab as a bioweapon (COVID-19 origins).	baseline
Primary	Online habits	We investigated the number of hours per day that participants' spent checking COVID-19 news and discussing COVID-19 on social media.	baseline